The Advisory Board Co. (NASDAQ:ABCO) has received a consensus rating of “Buy” from the nineteen research firms that are currently covering the firm. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and ten have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $44.82.

Several equities research analysts recently issued reports on ABCO shares. JPMorgan Chase & Co. started coverage on The Advisory Board in a research note on Friday, October 28th. They issued a “buy” rating and a $45.00 price objective for the company. Zacks Investment Research raised The Advisory Board from a “sell” rating to a “hold” rating in a research report on Monday, November 7th. Bank of America Corp. lowered The Advisory Board from a “buy” rating to an “underperform” rating in a research report on Monday, November 7th. Cantor Fitzgerald reaffirmed a “hold” rating on shares of The Advisory Board in a research report on Friday, August 19th. Finally, Credit Suisse Group AG reaffirmed a “buy” rating and issued a $50.00 target price on shares of The Advisory Board in a research report on Friday, September 16th.

In other The Advisory Board news, insider Cormac F. Miller sold 750 shares of the firm’s stock in a transaction that occurred on Wednesday, October 26th. The stock was sold at an average price of $41.63, for a total value of $31,222.50. Following the completion of the sale, the insider now owns 18,237 shares in the company, valued at approximately $759,206.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Hoose Mary Van sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 22nd. The stock was sold at an average price of $36.98, for a total value of $73,960.00. Following the completion of the sale, the insider now owns 37,386 shares of the company’s stock, valued at approximately $1,382,534.28. The disclosure for this sale can be found here. 2.90% of the stock is owned by company insiders.

Hedge funds have recently made changes to their positions in the company. American Capital Management Inc. increased its stake in shares of The Advisory Board by 6.6% in the second quarter. American Capital Management Inc. now owns 764,915 shares of the company’s stock worth $27,070,000 after buying an additional 47,235 shares in the last quarter. Swiss National Bank increased its stake in shares of The Advisory Board by 1.2% in the second quarter. Swiss National Bank now owns 69,700 shares of the company’s stock worth $2,467,000 after buying an additional 800 shares in the last quarter. Rail Splitter Capital Management LLC purchased a new stake in shares of The Advisory Board during the second quarter worth approximately $4,187,000. Ngam Advisors L.P. purchased a new stake in shares of The Advisory Board during the second quarter worth approximately $423,000. Finally, Rice Hall James & Associates LLC increased its stake in shares of The Advisory Board by 1.5% in the second quarter. Rice Hall James & Associates LLC now owns 360,064 shares of the company’s stock worth $12,743,000 after buying an additional 5,322 shares in the last quarter.

Shares of The Advisory Board (NASDAQ:ABCO) opened at 35.40 on Monday. The stock’s market cap is $1.42 billion. The Advisory Board has a one year low of $18.87 and a one year high of $54.83. The stock’s 50 day moving average price is $38.72 and its 200-day moving average price is $38.73.

The Advisory Board (NASDAQ:ABCO) last announced its quarterly earnings data on Tuesday, November 1st. The company reported $0.28 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by $0.12. The business earned $200.50 million during the quarter, compared to analysts’ expectations of $203.35 million. The Advisory Board had a positive return on equity of 11.28% and a negative net margin of 5.77%. The firm’s revenue was up .0% on a year-over-year basis. During the same period in the prior year, the company posted $0.33 earnings per share. On average, equities analysts predict that The Advisory Board will post $1.83 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Brokerages Set The Advisory Board Co. (ABCO) Price Target at $44.82” was first reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this article on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2016/12/01/brokerages-set-the-advisory-board-co-abco-price-target-at-44-82.html.

The Advisory Board Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.

5 Day Chart for NASDAQ:ABCO

Receive News & Stock Ratings for The Advisory Board Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Co. and related stocks with our FREE daily email newsletter.